Search tips
Search criteria

Results 1-1 (1)

Clipboard (0)
Year of Publication
Document Types
1.  Gene therapy using SOD1 protects striatal neurons from experimental stroke 
Neuroscience letters  2006;411(1):32-36.
Reactive oxygen species contribute to neuronal death following cerebral ischemia. Prior studies using transgenic animals have demonstrated the neuroprotective effect of the antioxidant, copper/zinc superoxide dismutase (SOD1). In this study we investigated whether SOD1 overexpression using gene therapy techniques in non-transgenic animals would increase neuronal survival. A neurotropic, herpes simplex virus-1 (HSV-1) vector containing the SOD1 gene was injected into the striatum either before or after transient focal cerebral ischemia. Striatal neuron survival at two days was improved by 52% when vector was delivered 12–15 hours prior to ischemia and by 53% when vector delivery was delayed 2 hours following ischemia. These data add to the growing literature which suggests that an antioxidant approach, perhaps by employing gene therapy techniques, may be beneficial in the treatment of stroke. (According to the guidline, it is mandatory to include classification terms here. But I did not find them –HZ)
PMCID: PMC1716259  PMID: 17110031
copper; zinc superoxide dismutase; gene therapy; stroke, focal ischemia, cerebral ischemia

Results 1-1 (1)